title: Impact of age and environment on somatic mutation at the hprt gene of T lymphocytes in humans.
abstract: Analysis of two human populations for dependence of somatic mutation on age has revealed both similarities and differences. The studies performed employed peripheral blood lymphocytes and measured the efficiency with which these cells form clones in vitro (cloning efficiency, CE) and the frequency of cells with inactivating mutations of the hypoxanthine phosphoribosyltransferase gene (mutant frequency, MF). The people studied were between 19 and 64 years of age. In one population, composed of 78 never smokers and 140 current smokers from the United States (US), both CE and MF were dependent on age: CE declined with age (p = 0.005); MF increased 0.15 per 10(6) cells per year of age for nonsmokers (p < 0.001) and at 1.3 times that rate for smokers (p = 0.01). In the second population, 80 people of unknown smoking status from Russia, the increase in MF per year was even greater, 2.5 times that of the US nonsmokers (p = 0.001) but the dependence of CE on age was the same as for the US population (p = 0.043). Because the increase of MF of the Russians with age is 2-fold greater than that of the US smokers, the intensity of smoking and/or other environmental exposures, or the susceptibility to these exposures, must account for the difference in age dependent MF increase, not the proportion of Russians that are smokers. Differences in the lymphocyte subpopulations that survived the longer transit from Russia may have contributed to the observed differences in MF. However, overall, the mutant frequency results suggest that the Russians were chronically exposed to higher levels of agents that induce somatic mutation and that, on an age adjusted basis, the Russia population studied is at increased risk for health consequences from accumulated genetic damage.
authors.affiliation: Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, CA 94551, USA.
authors.forename: I M
authors.initials: IM
authors.lastname: Jones
authors.forename: C B
authors.initials: CB
authors.lastname: Thomas
authors.forename: B
authors.initials: B
authors.lastname: Tucker
authors.forename: C L
authors.initials: CL
authors.lastname: Thompson
authors.forename: P
authors.initials: P
authors.lastname: Pleshanov
authors.forename: I
authors.initials: I
authors.lastname: Vorobtsova
authors.forename: D H
authors.initials: DH
authors.lastname: Moore
mesh_terms: D000328:Adult; D000375:Aging / Q000235:genetics*; D000925:Anticoagulants; D002951:Citrates; D019343:Citric Acid; D002999:Clone Cells; D004781:Environmental Exposure / Q000009:adverse effects*; D005260:Female; D005947:Glucose / Q000031:analogs & derivatives; D006493:Heparin; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000097:blood / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011830:Radiation Effects; D012044:Regression Analysis; D012426:Russia; D012907:Smoking / Q000009:adverse effects; D013601:T-Lymphocytes / Q000166:cytology / Q000201:enzymology*; D014481:United States
chemical_list: D000925:Anticoagulants; D002951:Citrates; C002113:acid citrate dextrose; D019343:Citric Acid; D006493:Heparin; D007041:Hypoxanthine Phosphoribosyltransferase; D005947:Glucose